EMEA-001269-PIP01-12 - paediatric investigation plan
Rosuvastatin
acetylsalicylic acid
PIPHuman
Key facts
- Active Substance
- Rosuvastatin
- acetylsalicylic acid
- Therapeutic area
- Cardiovascular diseases
- Decision number
- P/0223/2012
- PIP number
- EMEA-001269-PIP01-12
- Pharmaceutical form(s)
- Film-coated tablet
- Gastro-resistant tablet
- Condition(s) / indication(s)
- Treatment of cardiovascular disease
- Route(s) of administration
- Oral use
- Contact for public enquiries
EGIS Pharmaceuticals PLC
Hungary
registry@egis.hu
Phone: +36 18032414
Fax: +36 18032415- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date